Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-04 Ward Anne Sempowski Director Grant or award +41,600 160,667
2025-06-05 Ward Anne Sempowski Director Grant or award +59,225 119,067
2024-05-17 Ward Anne Sempowski Director Grant or award +20,529 59,842
2024-05-17 Ward Anne Sempowski Director Grant or award · Stock Option (right to buy) +37,578 37,578
2023-06-08 Ward Anne Sempowski Director Grant or award +17,307 39,313
2023-06-08 Ward Anne Sempowski Director Grant or award · Stock Option (right to buy) +33,960 33,960
2022-06-16 Ward Anne Sempowski Director Grant or award +12,006 22,006
2022-06-16 Ward Anne Sempowski Director Grant or award · Stock Option (right to buy) +24,707 24,707
2021-06-10 Ward Anne Sempowski Director Grant or award +5,000 10,000
2021-06-10 Ward Anne Sempowski Director Grant or award · Stock Option (right to buy) +10,000 10,000
2020-06-11 Ward Anne Sempowski Director Grant or award +5,000 5,000
2020-06-11 Ward Anne Sempowski Director Grant or award · Stock Option (right to buy) +10,000 10,000
2019-10-28 Ward Anne Sempowski Director Grant or award · Stock Option (right to buy) +35,000 35,000

Page 1 of 1 · 13 trades